The GLP is committed to full transparency. Download and review our Annual Report.

Acne’s Wonder Drug Is a Mental-Health Puzzle

| | July 15, 2019

In 2002, a family filed a lawsuit alleging that an acne drug made their teenage son suicidal. Accutane, a since-discontinued brand name for the drug isotretinoin, works wonders for cysts and pimples that don’t respond to other treatments. But since the FDA approved isotretinoin in 1982, it had been plagued by controversy over whether it could alter brain chemistry and cause depression. 

[In] a study published [July 3] in JAMA Dermatology contends that, for all the focus on these most dramatic side effects, dermatologists and psychiatrists might have overlooked other potential mental-health risks for patients taking the drug.

Read full, original post: Acne’s Wonder Drug Is a Mental-Health Puzzle

Related article:  Personal DNA tests challenged for perpetuating 'false notions' of ethnic cultures and race
The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend